Effects of Peloid Therapy in Patients With Carpal Tunnel Syndrome
Investigation of the Effects of Peloidotherapy on Pain Severity, Functional Status, and Ultrasonographic Findings in Patients With Carpal Tunnel Syndrome: A Randomized, Prospective, Single-Blind Study
1 other identifier
interventional
70
1 country
1
Brief Summary
Carpal tunnel syndrome is a common condition caused by pressure on a nerve at the wrist. It can lead to pain, numbness, weakness, and difficulty using the hand during daily activities. In this clinical trial, researchers will study a non-drug treatment approach for people with carpal tunnel syndrome. Participants will be randomly assigned to one of two groups. One group will receive a wrist splint and a home exercise program. The other group will receive peloidotherapy in addition to the same splint and exercise program. Pain, hand function, daily activities, quality of life, hand strength, and ultrasound findings of the median nerve will be evaluated before treatment, at the end of treatment, and during follow-up periods. The goal of this study is to determine whether adding peloidotherapy to wrist splint and a home exercise program provides additional benefits in reducing pain and improving hand function in people with carpal tunnel syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2026
CompletedFirst Submitted
Initial submission to the registry
February 4, 2026
CompletedFirst Posted
Study publicly available on registry
February 18, 2026
CompletedFebruary 18, 2026
February 1, 2026
3 months
February 4, 2026
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Boston Carpal Tunnel Questionnaire (BCTQ)
Symptom severity and functional status measured using the Boston Carpal Tunnel Questionnaire (BCTQ), which includes Symptom Severity and Functional Status subscales. Each item is scored from 1 to 5 and subscale scores are calculated as the mean of item scores. Higher scores indicate worse symptoms and functional limitation.
Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), 3-month follow-up (week 15)
Secondary Outcomes (5)
Median Nerve Cross-Sectional Area
Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), and 3-month follow-up (week 15).
QuickDASH Score
Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), 3-month follow-up (week 15)
Visual Analog Scale for Pain at Rest
Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), 3-month follow-up (week 15)
Visual Analog Scale for Pain During Activity
Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), 3-month follow-up (week 15)
Visual Analog Scale for Night Pain
Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), 3-month follow-up (week 15)
Other Outcomes (3)
Short Form-12 Health Survey Scores (SF-12)
Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), and 3-month follow-up (week 15).
DN4 Neuropathic Pain Questionnaire Score
Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), and 3-month follow-up (week 15).
Hand Grip Strength
Baseline (week 0), end of treatment (week 3), 1-month follow-up (week 7), and 3-month follow-up (week 15).
Study Arms (2)
Non-Peloid Therapy Group
ACTIVE COMPARATORParticipants receive treatment consisting of wrist splinting and a structured home exercise program. No peloid therapy is administered.
Peloid Therapy Group
EXPERIMENTALParticipants receive wrist splinting and a structured home exercise program in addition to peloid therapy. Peloid therapy is applied at 45 °C for 30 minutes per session, for a total of 15 sessions.
Interventions
Peloid therapy is applied at 45 °C for 30 minutes per session, for a total of 15 sessions.
Participants used a neutral-position wrist splint as part of conservative treatment for carpal tunnel syndrome.
Participants performed a standardized home exercise program including median nerve gliding exercises and tendon gliding exercises for the wrist and hand.
Eligibility Criteria
You may qualify if:
- Patients with mild or mild-to-moderate carpal tunnel syndrome confirmed by electromyography (EMG)
- Presence of clinical symptoms for at least 3 months
- Age 18 years and older
- No limitation in wrist joint range of motion
You may not qualify if:
- Cervical radiculopathy
- Polyneuropathy
- Pregnancy
- Presence of underlying metabolic diseases (diabetes mellitus, inflammatory rheumatic diseases, thyroid disorders)
- Presence of hand osteoarthritis
- Previous wrist or hand surgery
- Severe carpal tunnel syndrome confirmed by electromyography (EMG)
- Thenar muscle atrophy
- Corticosteroid injection for carpal tunnel syndrome or use of a wrist splint within the last 6 months
- History of malignancy
- Receipt of peloid therapy or any physical therapy modality for carpal tunnel syndrome within the last 6 months
- Contraindications to peloid therapy (impaired skin integrity or active infection at the application site)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziosmanpaşa Training and Research Hospital
Istanbul, Turkey (Türkiye)
Related Publications (4)
Tezcan S, Ulu Ozturk F, Uslu N, Nalbant M, Umit Yemisci O. Carpal Tunnel Syndrome: Evaluation of the Effects of Low-Level Laser Therapy With Ultrasound Strain Imaging. J Ultrasound Med. 2019 Jan;38(1):113-122. doi: 10.1002/jum.14669. Epub 2018 Jun 11.
PMID: 29892976BACKGROUNDYigit F, Ordahan B. Effects of high-intensity laser therapy on pain, functional status, hand grip strength, and median nerve cross-sectional area by ultrasonography in patients with carpal tunnel syndrome. Lasers Med Sci. 2023 Oct 31;38(1):248. doi: 10.1007/s10103-023-03913-z.
PMID: 37906312BACKGROUNDMetin Okmen B, Kasapoglu Aksoy M, Gunes A, Eroksuz R, Altan L. Effectiveness of PELOID therapy in carpal tunnel syndrome: A randomized controlled single blind study. Int J Biometeorol. 2017 Aug;61(8):1403-1410. doi: 10.1007/s00484-017-1317-1. Epub 2017 Feb 16.
PMID: 28210859BACKGROUNDSirin Ahisha B, Akkaya Ari S, Paker N, Kesiktas N, Barut Y. Comparison of the efficacy of peloid therapy and paraffin treatment in carpal tunnel syndrome. Int J Biometeorol. 2025 Aug;69(8):1957-1967. doi: 10.1007/s00484-025-02941-4. Epub 2025 May 13.
PMID: 40358708BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ebru Yılmaz Yalçınkaya, MD
Department of Physical Medicine and Rehabilitation, Gaziosmanpaşa Training and Research Hospital, Istanbul, Turkey
- PRINCIPAL INVESTIGATOR
Serap Seringeç Karabulut, MD
Department of Medical Ecology and Hydroclimatology, Gaziosmanpaşa Training and Research Hospital, Istanbul, Turkey
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor was blinded to group allocation. No other participants or study personnel were masked.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Physician in Physical Medicine and Rehabilitation
Study Record Dates
First Submitted
February 4, 2026
First Posted
February 18, 2026
Study Start
June 1, 2025
Primary Completion
September 11, 2025
Study Completion
January 15, 2026
Last Updated
February 18, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to ethical and legal restrictions related to patient confidentiality and institutional policies.